Drug screening in urine
Material: | 10 ml urine |
Methods: |
Ligandenassays → Enzym-Multiplied-Immunoassay (EMIT) Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie Ligandenassays → Cloned Enzyme Donor Immunoassay (CEDI) | Reference range | See findings report |
Indication | Suspicion of drug abuse, intoxication, abstinence checks |
Please note | Simple drug screening (abbreviation: DRU1): Test for cannabinoids, cocaine, benzoylecgonine, amphetamines, methamphetamines, MDA, MDMA, opiates, methadone or EDDP by immunoassay.
Standard drug screening (abbreviation DRU2): Test for cannabinoids, cocaine, benzoylecgonine, amphetamines, methamphetamines, MDA, MDMA, opiates, methadone or EDDP by immunoassay as well as test for opiates, benzodiazepines via LC-MS/MS. When this test series is requested, we use a chromatographic method (LC-MS/MS) in addition to the immunological tests, especially for the differentiation of opiates (Morphine, 6-monoacetylmorphin, codeine, dihydrocodeine) and benzodiazepines (Diazepam, nordiazepam, oxazepam, bromazepam, flunitrazepam, 7-aminoflunitrazepam, lorazepam) as well as Z-substances (Zolpidem, zopiclone, zaleplon). This way you will receive knowledge about your patient’s drug consumption and concomitant consumption within the shortest amount of time and with only minimal analytical expenditure.
Drug- plus medication screening (abbreviation: DRU3): As per DRU2 with additional testing for tricyclic antidepressants and medication (approximately 4000 substances).
Opioid screening (abbreviation: OPIOIU):
Alcohol markers:
Advantages of the screening methods (DRU1, DRU2, DRU3):
Confirmation analysis for quick screening test: If desired, positive results from an immunochemical quick screening in the urine, obtained in your practice, can be confirmed from the leftover material with a chromatographic method.
Test for new psychoactive substances (NPS): It is possible to demonstrate a large number of modern designer drugs such as synthetic cannabinoids and cathinones as well as tryptamine- and piperazine derivates in the urine with classical methods such as GC-MS as well as with new analytical methods, especially LC-MS/MS and Q-TOF. The spectrum of substances covered is continuously increased. |
More Results for the letter A
- Alpha-1 antitrypsin in the serum, phenotyping (A1APT)
- Alpha-1 antitrypsin, genotyping (A1AGEN)
- Alpha-1 microglobulin in the serum (A1M)
- Alpha-1 microglobulin in the urine (A1MGU)
- Alpha-2 macroglobulin in the serum (A2MG)
- Alpha-2 macroglobulin in the urine (A2MGU)
- Alprazolam (ALPR)
- Aluminium in the serum (ALU)
- Aluminium in the urine (ALUU)
- Alveolar glomerular basal membrane autoantibodies (ALVBA)
- GBM-antibodies
- Amanitine (AAMAN)
- Amantadine (AMAN)
- Amebiasis (AME)
- Amino acids in the blood (AS)
- Amino acids in the urine (ASU)
- Aminoglycoside antibiotics (AMGL)
- Amiodarone (AMIO)
- Amisulpride (AMISU)
- Ammonia (AMMON)
- Amoeba (AMOE)
- Entamoeba histolytica/dispar
- Amphetamines, methamphetamines, MDA, MDEA, MDMA (AMPH)
- Speed, crystal, meth, ecstasy
- Amylase in the serum (AMY)
- Amylase in urine (AMYL03)
- Amyloid A protein (AMYL04)
- Amyloid beta 1-42 protein (BETA42)
- ANA (ANF) (ANA)
- Antinuclear autoantibodies
- Anaerobic infections (KULAN)
- ANCA, c-, p-, atypical (ANCA)
- anti-neutrophil cytoplasmic antibodies
- Ancylostoma duodenale (ANCY)
- Androstendion (ANDR)